117 related articles for article (PubMed ID: 30064493)
21. FGF2 as a potential prognostic biomarker for proneural glioma patients.
Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
[TBL] [Abstract][Full Text] [Related]
22. Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis.
Miyar A; Habibi I; Ebrahimi A; Mansourpour D; Mokarizadeh A; Rajabi A; Farshgar R; Eshaghzadeh M; Zamani-Ahmadmahmudi M; Nodushan SM
J Neurol Sci; 2016 Sep; 368():314-7. PubMed ID: 27538656
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
Ogura R; Tsukamoto Y; Natsumeda M; Isogawa M; Aoki H; Kobayashi T; Yoshida S; Okamoto K; Takahashi H; Fujii Y; Kakita A
Neuropathology; 2015 Aug; 35(4):324-35. PubMed ID: 25950388
[TBL] [Abstract][Full Text] [Related]
24. Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma.
Tanaka K; Sasayama T; Mizukawa K; Takata K; Sulaiman NS; Nishihara M; Kohta M; Sasaki R; Hirose T; Itoh T; Kohmura E
Clin Neurol Neurosurg; 2015 Nov; 138():37-44. PubMed ID: 26276726
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
[TBL] [Abstract][Full Text] [Related]
26. Molecular markers in low-grade gliomas: predictive or prognostic?
Hartmann C; Hentschel B; Tatagiba M; Schramm J; Schnell O; Seidel C; Stein R; Reifenberger G; Pietsch T; von Deimling A; Loeffler M; Weller M;
Clin Cancer Res; 2011 Jul; 17(13):4588-99. PubMed ID: 21558404
[TBL] [Abstract][Full Text] [Related]
27. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L
Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679
[TBL] [Abstract][Full Text] [Related]
29. HDAC3 Expression Correlates with the Prognosis and Grade of Patients with Glioma: A Diversification Analysis Based on Transcriptome and Clinical Evidence.
Zhong S; Fan Y; Wu B; Wang Y; Jiang S; Ge J; Hua C; Zhao G; Chen Y; Xu H
World Neurosurg; 2018 Nov; 119():e145-e158. PubMed ID: 30053564
[TBL] [Abstract][Full Text] [Related]
30. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
[TBL] [Abstract][Full Text] [Related]
31. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
32. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
33. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis.
Lu VM; Alvi MA; McDonald KL; Daniels DJ
J Neurosurg Pediatr; 2018 Nov; 23(3):308-316. PubMed ID: 30544362
[TBL] [Abstract][Full Text] [Related]
34. Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma.
Yu Y; Sun L; Ren N; Li Y; Rong L; Zhao G
Int J Clin Exp Pathol; 2014; 7(11):8071-6. PubMed ID: 25550853
[TBL] [Abstract][Full Text] [Related]
35. Risk stratification of pediatric high-grade glioma: a newly proposed prognostic score.
Muhammed A; Gaber MS; Elbeltagy M; El Hemaly A; Taha H; Refaat A; Zaghluol MS
Childs Nerv Syst; 2019 Dec; 35(12):2355-2362. PubMed ID: 31218465
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
37. Tumor location and patient age predict biological signatures of high-grade gliomas.
Altieri R; Zenga F; Ducati A; Melcarne A; Cofano F; Mammi M; Di Perna G; Savastano R; Garbossa D
Neurosurg Rev; 2018 Apr; 41(2):599-604. PubMed ID: 28856492
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
[TBL] [Abstract][Full Text] [Related]
40. MGMT as a potential stratification marker in relapsed high-grade glioma of children: the HIT-GBM experience.
Schlosser S; Wagner S; Mühlisch J; Hasselblatt M; Gerss J; Wolff JE; Frühwald MC
Pediatr Blood Cancer; 2010 Feb; 54(2):228-37. PubMed ID: 19856394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]